Publication

Article

Cardiology Review® Online

June 2008
Volume25
Issue 6

Failed amiodarone therapy leads to pacemaker implantation in an elderly woman

An 80-year-old woman presented to the emergency department after awakening with substernal chest pain, shortness of breath, and palpitations.

An 80-year-old woman presented to the emergency department after awakening with substernal chest pain, shortness of breath, and palpitations. Her medical history included 3-vessel coronary artery disease, for which she had previously declined coronary artery bypass graft surgery; a non-ST-segment elevation myocardial infarction; and heart failure with preserved systolic function. She noted no previous arrhythmia symptoms, but had a history of slow heart rates, which was diagnosed during a recent evaluation for fatigue at an outside hospital. On arrival to our institution, the patient had an irregular pulse at 160 beats per minute, a blood pressure of 154/70 mm Hg, an increased respiratory rate, and an oxygen saturation of 88% on room air, which improved with administration of supplemental oxygen. Chest auscultation revealed decreased breath sounds at the lung bases; a rapid, “irregularly irregular” cardiac rhythm; and a systolic ejection murmur. An electrocardiogram (ECG) revealed atrial fibrillation with rapid ventricular response as well as mild (< 2 mm) ST-segment depression in the inferolateral leads. A chest radiograph showed small bilateral pleural effusions and mild pulmonary vascular congestion.

Figure 1. ECG showing sinus bradycardia at a rate of approximately 45 beats per

minute, which is followed by the onset of atrial fibrillation with rapid ventricular

response.

The patient was initially treated with oral and intravenous metoprolol, which lowered her ventricular rate to 90 beats per minute, resolving her chest pain and shortness of breath. She was admitted to the hospital to rule out myocardial infarction, and spontaneously converted to sinus rhythm within 24 hours. Due to her severe atrial fibrillation symptoms, she was started on oral amiodarone for maintenance of sinus rythym. An initial loading dose of 400 mg twice daily was associated with nausea, and the dose was lowered to 400 mg daily. She was discharged to home a few days later on amiodarone and metoprolol therapy, which were to be taken in addition to her usual daily medications.

Figure 2. ECG showing atrial fibrillation spontaneously terminating with a ~1.8 second

sinus pause, followed by sinus bradycardia at ~45 beats per minute.

The patient was readmitted to the hospital a few weeks later because of intermittent dizziness, which made her feel as though she were “about to pass out.” Sinus bradycardia with a rate of 45 beats per minute was observed, and metoprolol was discontinued (Figure 1). Telemetry monitoring over the next few days revealed self-limited paroxysms of atrial fibrillation. Upon termination of these episodes, several long pauses of up to 4 or 5 seconds were noted, and these were associated with dizziness (Figure 2). The decision was made to implant a dual-chamber pacemaker. One month after implantation, the patient had normal pacemaker function and no recurrent atrial fibrillation.

Related Videos
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orly Vardeny, PharmD: Finerenone for Heart Failure with EF >40% in FINEARTS-HF | Image Credit: JACC Journals
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Matthew Weir, MD: Prioritizing Cardiovascular Risk in Chronic Kidney Disease | Image Credit: University of Maryland
Erin Michos, MD: HFpEF in Women and Sex-Specific Therapeutic Approaches | Image Credit: Johns Hopkins
© 2024 MJH Life Sciences

All rights reserved.